NCT05701579

Brief Summary

Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will evaluate the technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
8mo left

Started Jul 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jul 2022Dec 2026

Study Start

First participant enrolled

July 1, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 27, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

January 27, 2023

Status Verified

January 1, 2023

Enrollment Period

3.5 years

First QC Date

January 6, 2023

Last Update Submit

January 25, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Range of motion

    Range of motion assessed by the means of goniometer

    At the 12 month of the follow-up

  • Range of motion

    Range of motion assessed by the means of goniometer

    At the 24 month of the follow-up

  • Knee anterior translatory stability

    Knee stability assessed by the means of Rollimeter-aided Lachman test - results will be presented in milimeters.

    At the 12 month of the follow-up

  • Knee anterior translatory stability

    Knee stability assessed by the means of Rollimeter-aided Lachman test - results will be presented in milimeters.

    At the 24 month of the follow-up

  • Knee anterolateral rotational stability

    Knee stability assessed by the means of pivot-shift test - results will be presented in grades

    At the 24 month of the follow-up

Secondary Outcomes (4)

  • The functional assessment with the The International Knee Documentation Committee Questionnaire (IKDC)

    At the 12 month of the follow-up

  • The functional assessment with the The International Knee Documentation Committee Questionnaire (IKDC)

    At the 24 month of the follow-up

  • The functional assessment with the Knee injury and Osteoarthritis Outcome Score (KOOS)

    At the 12 month of the follow-up

  • The functional assessment with the Knee injury and Osteoarthritis Outcome Score (KOOS)

    At the 24 month of the follow-up

Study Arms (1)

Patients with ACL Degeneratio Mucosa

Patients with ACL Degeneratio Mucosa

Procedure: ACL "decompression"

Interventions

The technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.

Patients with ACL Degeneratio Mucosa

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with ACL degeneratio mucosa decided to undergo a surgical treatment

You may qualify if:

  • patients with ACL degeneratio mucosa decided to undergo a surgical treatment
  • range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI

You may not qualify if:

  • non-adherence to the study protocol
  • active knee inflammation
  • range of motion impairment due to other extra- and intra-articular reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Artromedical Orthopaedic Clinic

Bełchatów, Łódź Voivodeship, 97-400, Poland

RECRUITING

Related Publications (4)

  • Gersing AS, Schwaiger BJ, Nevitt MC, Joseph GB, Feuerriegel G, Jungmann PM, Guimaraes JB, Facchetti L, McCulloch CE, Makowski MR, Link TM. Anterior cruciate ligament abnormalities are associated with accelerated progression of knee joint degeneration in knees with and without structural knee joint abnormalities: 96-month data from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2021 Jul;29(7):995-1005. doi: 10.1016/j.joca.2021.03.011. Epub 2021 Mar 26.

    PMID: 33775919BACKGROUND
  • Lintz F, Pujol N, Boisrenoult P, Bargoin K, Beaufils P, Dejour D. Anterior cruciate ligament mucoid degeneration: a review of the literature and management guidelines. Knee Surg Sports Traumatol Arthrosc. 2011 Aug;19(8):1326-33. doi: 10.1007/s00167-011-1433-0. Epub 2011 Feb 18.

    PMID: 21331652BACKGROUND
  • Sweed T, Mussa M, El-Bakoury A, Geutjens G, Metcalfe A. Management of mucoid degeneration of the anterior cruciate ligament: a systematic review. Knee Surg Relat Res. 2021 Aug 21;33(1):26. doi: 10.1186/s43019-021-00110-6.

    PMID: 34419162BACKGROUND
  • Lee JW, Ahn JT, Gwak HG, Lee SH. Clinical Outcomes of Arthroscopic Notchplasty and Partial Resection for Mucoid Degeneration of the Anterior Cruciate Ligament. J Clin Med. 2021 Jan 16;10(2):315. doi: 10.3390/jcm10020315.

    PMID: 33467062BACKGROUND

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Officials

  • Konrad Malinowski, MD PhD

    Artromedical Orthopaedic Clinic, Bełchatów, Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Konrad Malinowski, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Konrad Malinowski MD, Director of Artromedical Konrad Malinowski Clinic and Principal Investigator

Study Record Dates

First Submitted

January 6, 2023

First Posted

January 27, 2023

Study Start

July 1, 2022

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

January 27, 2023

Record last verified: 2023-01

Locations